Zoono Group EBIT Margin
The EBIT Margin (Operating Margin) of Zoono Group (ZNO.AX) as of Jun 24, 2026 is -2.95.In the previous year, EBIT Margin (Operating Margin) was -8.44 — a change of -65.02% (higher).
Get this data via API
Financial Data API
EBIT Margin
-2.95
YoY
-65.02%
Last updated:
EBIT Margin (Operating Margin) of Zoono Group is 2026 -2.95 . EBIT Margin (Operating Margin) of Zoono Group was 2025 -8.44 . It decreases by -65.02% higher compared to the previous year.
For Zoono Group, the operating (EBIT) margin of -295.1% is down versus 22.4% a few years ago.
Access this data via the Eulerpool API
Zoono Group Stock analysis
What does Zoono Group do? The Zoono Group Ltd is a globally operating company that develops and distributes antimicrobial solutions. The company was founded in New Zealand in 2009 and now has branches and distribution partners in Australia, USA, Canada, Europe, Asia, and South Africa.
The business model of Zoono is based on the development and marketing of antimicrobial solutions for use in various industries, such as healthcare, food industry, animal husbandry, and public buildings.
The goal of Zoono is to provide a safe and effective alternative to conventional cleaning and disinfection methods. Zoono's products contain special molecules that adhere to surfaces and form a barrier against bacteria, viruses, fungi, and algae.
Some of Zoono's products include hand disinfectants, surface disinfectants, air purifiers, and pet care products. The company places a strong emphasis on ensuring that these products are non-toxic, biodegradable, and environmentally friendly.
Zoono's solutions have already proven themselves in various industries. For example, they are successfully used in the food industry to prevent the growth of bacteria and mold. The products are also used in healthcare settings because of their long-lasting effectiveness, reducing the risk of infections.
In addition to antimicrobial solutions, Zoono also offers consulting services. The company develops individual solutions for customers and adapts the products to meet specific requirements and needs.
Thanks to the high effectiveness of their products, extensive network of partners and customers, and constant innovation of new solutions, Zoono has established itself as a successful and forward-thinking company in the industry.
In conclusion, the Zoono Group Ltd is an innovative and internationally operating company specializing in the development and marketing of antimicrobial solutions. Their business model is based on the development of safe and effective alternatives to conventional cleaning and disinfection methods. Thanks to the high effectiveness of their products and extensive network of partners and customers, Zoono has established itself as a leading provider in the industry. Zoono Group is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Zoono Group stock
EBIT Margin (Operating Margin) of Zoono Group amounted to -8.44 -2.95
Access this data via the Eulerpool API
Margins — Zoono Group
All Key Metrics — Zoono Group
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth